These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4095105)

  • 1. Induction chemotherapy of breast cancer.
    Hortobagyi GN; Buzdar AU; Ames FC; Blumenschein GR; Montague ED
    Prog Clin Biol Res; 1985; 201():105-16. PubMed ID: 4095105
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative chemotherapy in the treatment of inflammatory breast cancer.
    Keiling R; Guiochet N; Calderoli H; Hurteloup P; Krzisch C
    Prog Clin Biol Res; 1985; 201():95-104. PubMed ID: 4095121
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and histologic effects of preoperative combination chemotherapy of breast cancer].
    Wang ZY
    Zhonghua Wai Ke Za Zhi; 1988 Nov; 26(11):648-50, 700. PubMed ID: 2855506
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient.
    Porta C; Casagranda I; Semino G; Moroni M; Ratto C
    Haematologica; 1993; 78(1):56-7. PubMed ID: 8387943
    [No Abstract]   [Full Text] [Related]  

  • 5. A pilot evaluation of alternating preoperative chemotherapy in the management of patients with locoregionally advanced breast carcinoma.
    Pisansky TM; Loprinzi CL; Cha SS; Fitzgibbons RJ; Grant CS; Hass AC; Reuter NF; Wold LE; Ingle JN; Kardinal CG
    Cancer; 1996 Jun; 77(12):2520-8. PubMed ID: 8640701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mastectomy followed by cytoreductive chemotherapy in locally advanced breast cancer.
    Pluzańska A; Berner J; Dowgier-Witczak I; Malecka E; Pawlowski R; Wrezel E; Jeziorski A; Kamińska A; Tenderenda M
    J Chemother; 1989 Jul; 1(4 Suppl):1186-8. PubMed ID: 16312827
    [No Abstract]   [Full Text] [Related]  

  • 7. Early experiences of breast-conservation treatment combined with tamoxifen and CAF chemotherapy for breast cancer of stages I and II.
    Ogawa Y; Nishioka A; Inomata T; Hamada N; Terashima M; Yoshida S; Tanaka Y; Ogoshi S; Araki K; Kumon M
    Radiat Med; 1994; 12(1):29-35. PubMed ID: 8016401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretory breast carcinoma--case report and review of the medical literature.
    Costa NM; Rodrigues H; Pereira H; Pardal F; Matos E
    Breast; 2004 Aug; 13(4):353-5. PubMed ID: 15325674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
    Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
    J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome.
    Sataloff DM; Mason BA; Prestipino AJ; Seinige UL; Lieber CP; Baloch Z
    J Am Coll Surg; 1995 Mar; 180(3):297-306. PubMed ID: 7874340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New development of treatment for locally advanced breast cancer.
    Pinedo HM
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():272-3. PubMed ID: 10895164
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant chemotherapy for high-risk operable breast cancer.
    Buzdar AU
    J Clin Oncol; 2007 May; 25(13):1642-4. PubMed ID: 17404366
    [No Abstract]   [Full Text] [Related]  

  • 13. Intensive multi-drug post-operative chemotherapy for high risk stage II breast cancer.
    Shetty PA; D'Souza LJ; Shinde SR; Jussawalla DJ
    Indian J Cancer; 1983; 20(4):211-4. PubMed ID: 6676170
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intensive chemotherapy in day hospitals].
    Farnault G
    Soins Gynecol Obstet Pueric Pediatr; 1985 Mar; (46):45-8. PubMed ID: 3847184
    [No Abstract]   [Full Text] [Related]  

  • 15. [A resected case of squamous cell carcinoma of the breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases].
    Hiramatsu K; Kato K; Hirata A; Matsuba H; Hara T; Ito T; Miyata T; Akagawa T; Kutsuna Y; Machiki Y; Fujioka S
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):443-6. PubMed ID: 17353640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical management of inflammatory breast cancer.
    Singletary SE
    Semin Oncol; 2008 Feb; 35(1):72-7. PubMed ID: 18308148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neoadjuvant chemotherapy of patients with breast carcinoma].
    Jakesz R; Taucher S; Gnant M; Gebhard B; Kandioler D; Rudas M; Djavanmard M; Steger G
    Zentralbl Chir; 1998; 123 Suppl 5():147-50. PubMed ID: 10063601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neoadjuvant therapy followed by administration of UFT for breast cancer patients].
    Kataoka T; Goto T; Haruta R; Dohi K
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):369-72. PubMed ID: 8712833
    [No Abstract]   [Full Text] [Related]  

  • 20. Breast cancer management: recent advances and recommendations.
    Levine RM; Lippman ME
    Adv Intern Med; 1984; 29():215-44. PubMed ID: 6369926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.